These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31213765)

  • 1. Population pharmacokinetic analysis of tramadol and
    Lee J; Yoo HD; Bae JW; Lee S; Shin KH
    Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of
    Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
    Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
    J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
    Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk.
    Salman S; Sy SK; Ilett KF; Page-Sharp M; Paech MJ
    Eur J Clin Pharmacol; 2011 Sep; 67(9):899-908. PubMed ID: 21394525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Neuvonen M; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1293-301. PubMed ID: 23242004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid.
    Yu H; Hong S; Jeong CH; Bae JW; Lee S
    Arch Pharm Res; 2018 Mar; 41(3):288-298. PubMed ID: 29196917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
    Arafa MH; Atteia HH
    Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study.
    Yu H; Choi M; Jang JH; Park B; Seo YH; Jeong CH; Bae JW; Lee S
    Arch Pharm Res; 2018 May; 41(5):554-563. PubMed ID: 29524157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration.
    Porażka J; Szałek E; Połom W; Czajkowski M; Grabowski T; Matuszewski M; Grześkowiak E
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):579-584. PubMed ID: 30778911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study.
    Allegaert K; Holford N; Anderson BJ; Holford S; Stuber F; Rochette A; Trocóniz IF; Beier H; de Hoon JN; Pedersen RS; Stamer U
    Clin Pharmacokinet; 2015 Feb; 54(2):167-78. PubMed ID: 25258277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
    Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
    J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and
    Jeong HC; Bae SH; Bae JW; Lee S; Kim A; Jang Y; Shin KH
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31744222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.
    Allegaert K; Anderson BJ; Verbesselt R; Debeer A; de Hoon J; Devlieger H; Van Den Anker JN; Tibboel D
    Br J Anaesth; 2005 Aug; 95(2):231-9. PubMed ID: 15951326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
    Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
    Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.